CIPLA.NS Cipla Limited
P/E
29.987501
Forward P/E
22.675426
Price/Sales
4.1785946
Beta
0.113
Div Yield
0.009000000000000001%
Market Cap
--
Company Analysis
Latest News
Cipla's Compliance Crisis Deepens: Can India's Third-Largest Drugmaker Reassure Investors After Losing a Key License?
Reports emerged this week that Cipla, one of India's most trusted pharmaceutical names, suffered a regulatory blow when Maharashtra's Food and Drug...
Cipla loses Pune distribution license, citing misbranded Reactin Plus
The Maharashtra Food and Drug Administration (FDA) cancelled the drug sale and distribution license for Cipla Pharma & Life Sciences' Pune facility. This...
Cipla Shares Sink, Rattled by Trump’s Proposed 200% US Generic Tariffs
Cipla shares fell as much as 2.5% on July 22, 2026. Other prominent Indian pharmaceutical stocks also declined during the session. The sell-off follows US...